A Phase I, Double-Blind, Randomized, Placebo-Controlled, Single Dose-Escalation Study to Evaluate the Tolerability, and Safety of Cytisinicline in Adult Smokers
AuthID
P-00X-FAH
P-00X-FAH
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service